External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology ESOPRS 2024
Roche and Genentech at

ESOPRS 2024

September 12 - September 14
Rotterdam, Netherlands
esoprs.eu
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
01:30 PM
Duration 5mins Rotterdam, Netherlands
Interleukin-6 (IL-6) Receptor Signalling Inhibition With Satralizumab in Thyroid Eye Disease (TED): Phase 3 SatraGO-1 and SatraGO-2 Trial Design
Daniel Ezra
Ophthalmology | Thyroid eye disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.